|
Dr. Paul Bloom
Quotient Pharmaceuticals Manufacturing Executive Vice President, Board Member Dr. Bloom is a key member of the management team at Quotient and has devoted years of study to the blood plasma industry and is experienced in the regulatory process. His background in theoretical physics and other disciplines as a technology analyst have proved invaluable to our Company. He has spent the last 7+ years working with David Pollack in developing a vast knowledge base across virtually all facets of Quotient’s business. Dr. Bloom has executed the primary market/competitive research, regulatory and clinical trial modeling and financial modeling along with other activities. He has decades of experience as an investment banker and analyst raising capital for emerging companies. Dr. Bloom has worked for some of the largest investment banks as an analyst for Goldman Sachs, Citicorp, and J.P. Morgan. |